NBGEX | VEXPX | NBGEX / VEXPX | |
Total Expense Ratio | 1.09 | 0.45 | 242% |
Annual Report Gross Expense Ratio | 1.09 | 0.45 | 242% |
Fund Existence | 32 years | 57 years | - |
Gain YTD | -11.384 | -11.214 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.74B | 19.8B | 44% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | -5.56 | -8.74 | 64% |
Returns for 3 years | -5.42 | -3.36 | 161% |
Returns for 5 years | 16.79 | 20.55 | 82% |
Returns for 10 years | -2.38 | 2.88 | -83% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 25.22 | 0.21 | +0.84% |
First Trust Nasdaq Pharmaceuticals ETF | |||
CGCP | 22.34 | 0.07 | +0.31% |
Capital Group Core Plus Income ETF | |||
IAPR | 27.97 | 0.08 | +0.28% |
Innovator Intl Dev Pwr Bffr ETF Apr | |||
JPIB | 48.15 | 0.07 | +0.15% |
JPMorgan International Bond Opps ETF | |||
EVX | 34.91 | N/A | N/A |
VanEck Environmental Svcs ETF |